Author(s):
Fernandes, MG ; Dias, M ; Santos, R ; Ravara, S ; Fernandes, P ; Firmino-Machado, J ; Antunes, JP ; Fernandes, O ; Madureira, A ; Hespanhol, V ; Rodrigues, C ; Vicente, CA ; Alves, S ; Mendes, G ; Ilgenfritz, R ; Pinto, BS ; Alves, J ; Saraiva, I ; Bárbara, C ; Cipriano, MA ; Figueiredo, A ; Uva, MS ; Jacinto, N ; Curvo-Semedo, L ; Morais, A
Date: 2024
Persistent ID: http://hdl.handle.net/10400.26/51837
Origin: Saúde - CUF
Subject(s): Neoplasias do Pulmão/diagnóstico por imagem; Lung Neoplasms/diagnostic imaging
Description
Lung cancer (LC) is a leading cause of cancer-related mortality worldwide. Lung Cancer Screening (LCS) programs that use low-dose computed tomography (LDCT) have been shown to reduce LC mortality by up to 25 % and are considered cost-effective. The European Health Union has encouraged its Member States to explore the feasibility of LCS implementation in their respective countries. The task force conducted a comprehensive literature review and engaged in extensive discussions to provide recommendations. These recommendations encompass the essential components required to initiate pilot LCS programs following the guidelines established by the World Health Organization. They were tailored to align with the specific context of the Portuguese healthcare system. The document addresses critical aspects, including the eligible population, methods for issuing invitations, radiological prerequisites, procedures for reporting results, referral processes, diagnostic strategies, program implementation, and ongoing monitoring. Furthermore, the task force emphasized that pairing LCS with evidence-based smoking cessation should be the standard of care for a high-quality screening program. This document also identifies areas for further research. These recommendations aim to guarantee that the implementation of a Portuguese LCS program ensures high-quality standards, consistency, and uniformity across centres.
